Detalles de la búsqueda
1.
Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Nature;
597(7878): 732-737, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526717
2.
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
Oncologist;
28(11): e1065-e1074, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156009
3.
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.
BMC Cancer;
20(1): 83, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005111
4.
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
J Thorac Oncol;
19(3): 500-506, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012986
5.
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets.
JTO Clin Res Rep;
5(2): 100623, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357092
6.
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
JCO Precis Oncol;
7: e2200540, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716413
7.
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.
Clin Cancer Res;
29(23): 4958-4972, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37733794
8.
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
JTO Clin Res Rep;
4(8): 100533, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649681
9.
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Nat Commun;
14(1): 695, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755027
10.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov;
13(7): 1556-1571, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068173
11.
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Lancet Digit Health;
5(7): e404-e420, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268451
12.
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer;
23(3): 236-243, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216923
13.
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
JAMA Netw Open;
5(6): e2215589, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666500
14.
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma.
Cancers (Basel);
14(14)2022 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884533
15.
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
Nat Commun;
13(1): 1797, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379845
16.
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations.
JTO Clin Res Rep;
2(11): 100237, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820641
17.
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition.
Clin Cancer Res;
27(6): 1720-1733, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33323404
18.
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
Chest;
159(3): 1256-1264, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217413
19.
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.
JCO Precis Oncol;
52021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377884
20.
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
J Thorac Oncol;
16(4): 601-609, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388476